PATENT CLAIM ANALYSIS

Application Number: 15780980
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "456000"]

Abstract:
Compositions including the combination of cremastranone analogs and anti-angiogenic agents and the use of the compositions for targeting ocular angiogenesis such as seen in neovascular eye diseases are disclosed.

Claim (Index 1):
A composition comprising a synthetic compound comprising formula (I) wherein R 1 , R 2 , R 3 , R 4 , and R 5  are independently selected from the group consisting of hydrogen, hydroxyl, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, substituted alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocarbyl and substituted hydrocarbyl; and X, Y, and Z are independently selected from the group consisting of carbon, nitrogen, and oxygen, and\n an anti-angiogenic agent.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 94.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15889409', '14833041', '15512200', '15602096', '15058938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.678684042479132
- 35 USC 102 Novelty (BERT): 0.5543320240813467
- Combined Prediction Score: 0.6662488406393535
- Mean Citation Score: 319.820838
- Max Citation Score: 421.37485
- Similarity Product: 350.4517728085756

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test